leo 22811
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2009 (NCT00833872)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- leo 22811
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01211964 | Phase 1 | Sep 1, 2010 | Covance, Leo Pharma |
| NCT01116895 | Phase 2 | May 1, 2010 | Centre de Recherche Dermatologique du Quebec Metropolitaine, Leo Pharma |
| NCT00833872 | Phase 1 | Jan 1, 2009 | Covance, Leo Pharma |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Leo Pharma | For profit | 3 | 3 | 2 | 2009 |
| Covance | For profit | 2 | 0 | 1 | 2009 |
| Centre de Recherche Dermatologique du Quebec Metropolitaine | Academic/Hospital | 1 | 0 | 1 | 2010 |
3 organizations
Page 1 / 1